• LNP-NamiRNA Suppresses Pancreatic Cancer via Dual Pathways

  2026-06-28

  Yu et al. demonstrate that LNP-encapsulated mir-200c (a NamiRNA) suppresses pancreatic cancer proliferation and migration through two distinct regulatory mechanisms: activation of PTPN6 transcription and repression of CDH17 expression. This dual-action approach highlights new therapeutic strategies and provides mechanistic insight into nuclear miRNA regulation in aggressive tumors.

• Lithium-Engineered Exosomal Wnt10a Boosts Osteogenesis via β

  2026-06-27

  This study uncovers how lithium enhances osteogenesis by promoting Rab11a-mediated exosomal Wnt10a secretion from BMSCs, leading to activation of the Wnt/β-catenin pathway. These mechanistic insights support refined engineering of stem cell exosomes for bone regeneration and highlight the value of targeted Wnt pathway modulation in regenerative medicine.

• Dabigatran Etexilate: Redefining Oral Anticoagulation Pathwa

  2026-06-26

  The reference review establishes dabigatran etexilate as the first oral direct thrombin inhibitor to overcome limitations of traditional anticoagulants, notably by bypassing cytochrome P450 metabolism and reducing the need for intensive laboratory monitoring. These advances improve safety, efficacy, and accessibility for stroke and VTE prevention, with major implications for drug-drug interaction research.

• Sodium Ascorbate: Innovative Mechanisms in Cancer Cell Death

  2026-06-26

  Explore the unique mechanistic role of Sodium Ascorbate, a mineral salt of ascorbic acid, in inducing necrotic tumor cell death via intracellular ROS. Discover advanced research insights and methodological guidance not covered in standard protocols.

• Optimizing Apoptosis Assays with MCL-1 Inhibitor A-1210477

  2026-06-25

  MCL-1 inhibitor A-1210477 empowers cancer researchers with high-specificity induction of mitochondrial apoptosis in MCL-1-dependent models. This article delivers actionable protocols, data-driven troubleshooting, and advanced workflow integration based on the latest mechanistic insights and benchmark comparisons.

• Phosbind Biotin: Sequence-Independent Phosphorylation Detect

  2026-06-25

  Phosbind Biotin transforms Western Blot workflows by enabling highly specific, antibody-independent detection of phosphorylated proteins, critical for dissecting post-translational regulation in signal transduction and plant stress biology. Leveraging dinuclear metal complex phosphate binding, this reagent empowers researchers with robust protocol flexibility and streamlined troubleshooting.

• Cy5 NHS ester(Et): Technical Guide for Fluorescent Labeling

  2026-06-24

  Cy5 NHS ester(Et) enables high-purity, water-soluble fluorescent labeling of amino groups in proteins and other biomolecules for detection in immunofluorescence, flow cytometry, and fluorescence microscopy workflows. It should not be used in ethanol-based protocols or where long-term storage of dye solutions is required. Correct handling and immediate use are critical to maintain reagent integrity and labeling efficiency.

• Hydroxytyrosol: Antioxidant Mechanisms and Cardiovascular Be

  2026-06-23

  Hydroxytyrosol, a phenolic compound found in olive oil, exhibits robust antioxidant and anti-inflammatory properties relevant to cardiovascular health research. Its mechanism involves direct ROS scavenging and modulation of inflammatory signaling. High-purity Hydroxytyrosol (N2302, APExBIO) offers reproducible parameters for in vitro oxidative stress and inflammation studies.

• DOT1L Inhibition Enhances Lenalidomide Efficacy in Myeloma

  2026-06-23

  The referenced study demonstrates that DOT1L inhibition reprograms innate immunity in multiple myeloma cells and significantly amplifies the immunomodulatory effects of lenalidomide. These findings establish a mechanistic basis for combining epigenetic and immune system activation strategies, offering a promising approach to overcome persistent therapeutic resistance in multiple myeloma.

• Polygodial as a TRPA1 Channel Activator: Protocols & Innovat

  2026-06-22

  Polygodial unlocks precision TRPA1 channel activation for sensory ion channel and airway inflammation research, offering reproducibility and robust signal modulation. This guide translates latest findings and workflows into actionable protocols, troubleshooting, and assay enhancements for neurophysiology and membrane transporter studies.

• Estradiol–Autophagy Axis: Organ Protection in Perimenopausal

  2026-06-22

  This study clarifies how declining estradiol during perimenopause drives multi-organ risk by disrupting estrogen receptor–mediated autophagy. Integrated analyses from human cohorts and mouse models reveal that estrogen replacement mitigates fibrosis and metabolic dysfunction through ERα and ERβ signaling, highlighting new targets for precision hormone therapy.

• Cy5.5 NHS Ester (Non-Sulfonated): Reliable NIR Labeling for

  2026-06-21

  This article provides a scenario-driven, evidence-based guide to using Cy5.5 NHS ester (non-sulfonated) (SKU A8103) for reproducible protein and cell labeling in advanced biomedical workflows. It addresses experimental design, protocol optimization, data interpretation, and vendor selection, offering practical insights for researchers seeking robust near-infrared fluorescence imaging solutions.

• BAPTA-AM: Precision Calcium Chelation for NMJ and Beyond

  2026-06-20

  Explore how BAPTA-AM, a cell-permeable calcium chelator, enables advanced investigation of neuromuscular junction formation and calcium signaling. This article uncovers distinct mechanistic insights and assay strategies, setting a new standard for calcium-dependent research applications.

• Hydroxychloroquine Sulfate for Autoimmune Disease Research P

  2026-06-19

  Hydroxychloroquine Sulfate (SKU B4874) is optimized for the inhibition of autophagy and TLR7/9 signaling in autoimmune disease research, including systemic lupus erythematosus and rheumatoid arthritis models. It is best used in aqueous-based workflows and is not suitable for protocols requiring organic solvents or long-term solution storage.

• Alosetron: 5-HT3 Receptor Antagonist for Stem Cell Research

  2026-06-19

  Alosetron’s selectivity for 5-HT3 receptors enables precise dissection of serotonin-driven mechanisms in gastrointestinal stem cell fate and epithelial polarity. This guide translates cutting-edge findings into practical protocols, revealing troubleshooting strategies and advanced applications for robust intestinal research.

473 records 8/32 page Previous Next First page 上5页 678910 下5页 Last page